We use cookies on this website. By continuing to use this site without changing your cookie settings, you agree that you are happy to accept our cookies and for us to access these on your device. Find out more about how we use cookies and how to change your cookie settings.

Brain pathways in ADHD and depression

A Cambridge Clinical Research Facility success story.

Studies in normal subjects mapped the chemical pathways, which regulate two aspects of cognitive brain function.

The results may have implications for the treatment of attention-deficit hyperactivity disorder (ADHD) and understanding the effects of antidepressant drugs.

The paper 'Neurochemical Modulation of Response Inhibition and Probabilistic Learning in Humans' was published in Science on 10 February 2006 (volume 311, no. 5762, pp. 861–863).

Find out more about the Cambridge Clinical Research Facility.

Image credit: Anthea Sieveking

Share |
Home  >  Funding  >  Biomedical science  >  Funded projects  >  Major initiatives  >  Clinical Research Facilities  > Brain pathways in ADHD and depression
Wellcome Trust, Gibbs Building, 215 Euston Road, London NW1 2BE, UK T:+44 (0)20 7611 8888